09:57 AM EST - Aeterna Zentaris Inc. : announced that Johanna Bendell, MD, Director of Gastrointestinal Cancer Research and Associate Director of Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, presented Phase 3 results for perifosine in refractory colorectal cancer yesterday, at the American Society of Clinical Oncology (ASCO) Annual Meeting which is being held in Chicago. Aeterna Zentaris Inc.
shares T.AEZ are trading down $0.01 at $0.46.
